Status:
NOT_YET_RECRUITING
Behavioral Safety and Fentanyl Education: BSAFE
Lead Sponsor:
San Francisco Department of Public Health
Conditions:
Drug Overdose
Drug Overdose Accidental
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who use stimulants who may have unintentional fentanyl use (UFU). It includes an es...
Eligibility Criteria
Inclusion
- Aged 18 years or older,
- Reports intentional cocaine or methamphetamine use \>15 of past 30 days,
- Urine positive for cocaine or methamphetamine and negative for opioids/fentanyl prior to enrollment
- Be able to provide the names of at least 2 persons who can consistently locate their whereabouts.
Exclusion
- Reports past 30-day intentional use of any opioid or ongoing use of an opioid antagonist (e.g., naltrexone)
- Intends to leave area in coming year,
- Unable to communicate in English or Spanish,
- Any other condition that, in the PI's judgment, interferes with safe study participation or adherence to study procedures.
Key Trial Info
Start Date :
December 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2030
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT07219082
Start Date
December 15 2025
End Date
January 15 2030
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco Department of Public Health
San Francisco, California, United States, 94102